<code id='74CE6F6DE5'></code><style id='74CE6F6DE5'></style>
    • <acronym id='74CE6F6DE5'></acronym>
      <center id='74CE6F6DE5'><center id='74CE6F6DE5'><tfoot id='74CE6F6DE5'></tfoot></center><abbr id='74CE6F6DE5'><dir id='74CE6F6DE5'><tfoot id='74CE6F6DE5'></tfoot><noframes id='74CE6F6DE5'>

    • <optgroup id='74CE6F6DE5'><strike id='74CE6F6DE5'><sup id='74CE6F6DE5'></sup></strike><code id='74CE6F6DE5'></code></optgroup>
        1. <b id='74CE6F6DE5'><label id='74CE6F6DE5'><select id='74CE6F6DE5'><dt id='74CE6F6DE5'><span id='74CE6F6DE5'></span></dt></select></label></b><u id='74CE6F6DE5'></u>
          <i id='74CE6F6DE5'><strike id='74CE6F6DE5'><tt id='74CE6F6DE5'><pre id='74CE6F6DE5'></pre></tt></strike></i>

          leisure time

          leisure time

          author:leisure time    Page View:52973
          Richard Burr
          North Carolina Senator Richard Burr received strong support from the biotech sector. Gerry Broome/AP

          WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

          North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

          advertisement

          Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          It's time to retire 'poor historian' from clinicians' vocabularies
          It's time to retire 'poor historian' from clinicians' vocabularies

          AdobeShouldwepitythe“poorhistorians”—theindividualsorfamilymemberswhocan’tgiveaclearaccountingofthei

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          Readers respond to H5N1 and livestock movements, and more

          MollyFergusonforSTATToencouragerobust,good-faithdiscussionaboutdifficultissues,STATpublishesselected